Latest fiscal year 2025 · computed deterministically from XBRL 10-K data · coverage 100%
In fiscal 2025, SkinHealth Systems Inc. reported revenue of $301M, down 10.0% year over year. Operating margin was -6.9% and net margin -3.2%, on a free-cash-flow margin of 12.4% with capital expenditure at 0.1% of revenue. Every figure is computed directly from SKIN's SEC XBRL 10-K filing — deterministic, with no estimates.
| Fiscal year | Revenue | Op margin | Net margin |
|---|---|---|---|
| FY2025 | $301M | -6.9% | -3.2% |
| FY2024 | $334M | -20.3% | -8.7% |
| FY2023 | $398M | -32.9% | -25.2% |
| FY2022 | $366M | -7.1% | 12.1% |
| FY2021 | $260M | -15.4% | -145.6% |
How does SKIN compare against its actual peer set?
A CompsDesk subscription covers unlimited benchmark packs on any covered company: up to 19 metrics (6 core guaranteed) × up to 5 fiscal years × up to 12 chosen peers, percentile placement, the subject's figures cited to their SEC tag, form and period with every company identified by its CIK, PDF-ready HTML + CSV, generated on demand.
Related in the same sector: A · ACHR · AEHR · AERG · AEVA · AIRI
Source: SEC EDGAR XBRL (10-K filings), latest filed values. "n/a" = not disclosed under mapped tags — never estimated. Informational benchmarking, not investment advice. © CompsDesk / Sam Arora.